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Adhesion Receptors Mediate Efficient Non-viral 
Gene Delivery
Inge S Zuhorn1,2, Dharamdajal Kalicharan3, George T Robillard1 and Dick Hoekstra2
1Biomade Technology Foundation, Nijenborgh, Groningen, The Netherlands; 2Department of Cell Biology/Membrane Cell Biology, University  
Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3Department of Cell Biology/Electron Microscopy,  
Groningen, The Netherlands 
For a variety of reasons, including production limitations, 
potential unanticipated side effects, and an immuno-
logical response upon repeated systemic administration, 
virus-based vectors are as yet not ideal gene delivery vehi-
cles, justifying further research into alternatives. Unlike 
viral vectors, non-viral vectors pose minimal health risks, 
but to meet therapeutic requirements their efficacy 
needs major improvement. This goal may be accom-
plished by better defining the mechanism of non-viral 
gene delivery and exploiting specific cellular properties. 
Here we demonstrate that transfection of epithelial cells 
with lipoplexes is almost exclusively mediated by the β1 
integrin cell surface receptor. More important, we show 
that in general, adhesion receptors can be exploited 
by lipoplexes to gain access to cells, including difficult- 
to-transfect primary neural stem cells and suspension 
cells, thereby leading to productive transfection. We pro-
pose that adhesion receptors serve as “natural” recep-
tors for lipoplexes. As no natural cellular receptors for 
lipoplexes have previously been identified, our results are 
an important step forward in understanding the mecha-
nisms of non-viral gene delivery. Moreover, the finding 
that adhesion receptors mediate efficient non-viral gene 
delivery paves the way for the optimization of (standard) 
transfection procedures as well as ex vivo gene therapy 
protocols using non-viral vectors.
Received 5 December 2006; accepted 8 February 2007; published online  
20 March 2007. doi:10.1038/mt. sj.6300139; corrected for print May 2007
IntroductIon
Successful gene therapy depends on efficient and safe delivery 
of a transgene into the desired tissue. As viruses are by nature 
designed to enter cells and exploit the host cell’s replication 
machinery, it seemed obvious to develop viral vectors for gene 
delivery. However, all viruses cause immune responses,1,2 which 
precludes subsequent administration of the same vector. More-­
over, two of the most popular viral vectors, i.e., retroviruses and 
adeno-­associated viruses, integrate into the host genome, posing 
the risk of insertional mutagenesis.3,4 Non-­viral vectors such as 
cationic lipid–DNA complexes (lipoplexes) are non-­immunogenic 
and non-­oncogenic, but their relatively low transfection efficiency 
compared with viral vectors is a major disadvantage.5 The seri-­
ous health concerns associated with application of viral vectors, 
in conjunction with options for further improvement of the 
rate-­limiting steps in non-­viral gene delivery,6–8 have intensified 
research into the application of non-­viral devices. In particular, 
current developments suggest that the need is less to synthesize 
novel vectors, and more to gain mechanistic insight to manipulate 
and hence improve transfection efficiency.
Recently, we have shown that clathrin-­mediated endocytosis 
represents a major cellular entry pathway for lipoplexes.9 This 
finding raised the question whether specific cell surface recep-­
tors are involved in lipoplex binding and/or internalization. Pre-­
viously, a role for proteoglycans in transfection was suggested, 
but as no data were provided on binding and internalization of 
lipoplexes, their exact role remains enigmatic.10 More specifically, 
we wondered whether the very nature of cationically charged 
lipoplexes of a given size, as used in our previous work, deter-­
mined their effective processing by “specific” cellular receptors, in 
a manner analogous to the binding and internalization of a viral 
particle by a given cell type. Thus rather than coupling a ligand 
to trigger specific ligand–receptor-­mediated uptake of lipoplexes, 
which often leads to an ambiguous outcome as it need not imply 
a ligand-­specific internalization of such targeted complexes,11 our 
aim in the current work was to identify native cellular receptors 
that “recognize” lipoplexes, thus exploiting cellular internalization 
machineries directly.
results
loss of cell–cell contact in MdcK monolayers  
promotes lipoplex binding and internalization
To identify a cellular receptor for lipoplexes, we used the epithelial 
Madin–Darby canine kidney (MDCK) cell line. When grown to 
confluence on porous filters, epithelial cells form tight monolay-­
ers. The cells in these monolayers are polarized, comprising an 
apical (luminal) and a basolateral domain physically separated by 
tight junctions, each with characteristic protein and lipid compo-­
sitions.12,13 To distinguish between the involvement of apical and 
basolateral receptors in cellular entry of lipoplexes, MDCK mono-­
layers were exposed to lipoplexes before and after disruption of 
the tight junctions with the calcium chelator ethylene glycol tet-­
raacetic acid (EGTA). This treatment results in the loss of cell–cell 
contact, leading to the accessibility of (baso)lateral receptors from 
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the apical side.14 It should be noted that the addition of lipoplexes 
to the basolateral side of polarized MDCK cells (i.e., to the basolat-­
eral chamber of a transwell filter system) does not result in bind-­
ing of lipoplexes because of their gravity-­induced sedimentation. 
Whereas lipoplex binding to the apical surface of MDCK cells is 
negligible, exposure of the basolateral cell surface upon loss of 
cell–cell contact results in massive lipoplex binding and a ninefold 
(from 2 to 20%) increase in transfection efficiency (Figure 1b–e).
To verify whether the enhancement in lipoplex binding 
results in a concomitant enhancement in lipoplex internalization, 
the lipoplex-­mediated nuclear delivery of fluorescein isothio-­
cyanate–labeled oligonucleotides (FITC-­ODNs) was measured. 
After their uptake by cells, ODNs passively diffuse into the cell’s 
nucleus. Therefore, the extent of nuclear accumulation of FITC-­
ODNs, delivered by lipoplexes, directly correlates with the extent 
of lipoplex internalization.15 Incubation of EGTA-­treated MDCK 
monolayers with lipoplexes containing FITC-­ODNs results in 
the appearance of ODNs in essentially all nuclei, although the 
intensity of the fluorescent signal varies. In sharp contrast, essen-­
tially no FITC-­ODN-­positive nuclei are observed in control cells 
(Figure 2). Evidently, upon loss of cell–cell contact between 
MDCK cells, lipoplex binding and internalization are signifi-­
cantly enhanced, ultimately resulting in a major boost in trans-­
fection efficiency.
Typically, after tight junction disruption, lipoplexes accumu-­
late at the cell surfaces of adjacent MDCK cells, i.e., the lateral 
plasma membrane domain (Figure 1b). These sites were visualized 
by electron microscopy (Figure 3b and c), and lipoplexes appeared 
to accumulate at the cell surface near/into coated pits (Figure 3c, 
arrows), consistent with lipoplex internalization via clathrin-­medi-­
ated endocytosis.9 In Figure 3d, the fingerprint structure that is 
typical for lipoplexes visualized by electron microscopy is clear. To 
obtain some mechanistic insight into the effect of tight junction 
disruption on the process that promotes lipoplex transfection, we 
took into account the fact that tight junction disruption involves 
actin cytoskeletal rearrangements.16 We examined the effect of 
the actin filament–disrupting drug cytochalasin D (cytD) in the 
context of the EGTA-­induced enhancement in lipoplex binding 
and transfection. As can be appreciated from Figure 1a, polarized 
MDCK cells show a continuous circumferential pattern of the 
tight junction protein ZO-­1, which indicates the presence of func-­
tional tight junctions. Upon EGTA treatment, ZO-­1 redistributes 
in part into the cytoplasm, coinciding with a loss of cell–cell contact 
(Figure 1a, EGTA). Prior disruption of the actin cytoskeleton 
by cytD maintains the lateral distribution of ZO-­1 upon EGTA 
treatment, although in a punctuate rather than continuous pat-­
tern (Figure 1a, cytD EGTA). Under these conditions, the typical 
rounding-­up of cells is prevented, and (consequently) the enhance-­
ment in lipoplex binding and transfection efficiency (Figure 1b–e). 




Figure 2 Prior loss of cell–cell contact between Madin–darby canine 
kidney (MdcK) cells increases the internalization of lipoplexes. After 
the internalization of lipoplexes containing oligonucleotides (ODNs) and 
their subsequent endosomal escape, ODNs passively diffuse into the cell’s 
nucleus. Therefore, the nuclear accumulation of fluorescein isothiocyanate 
(FITC)–labeled ODNs directly correlates with the extent of lipoplex internal-
ization. Incubation of ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA)–treated MDCK monolayers with Lipofectamine 
2000 lipoplexes containing FITC-ODNs results in the appearance of FITC-
ODNs in essentially all nuclei, although the intensity of the fluorescent 
signal varies. In sharp contrast, essentially no FITC-ODNs are observed in 
monolayers that were not pre-treated with EGTA. Nuclei counterstained 
with DAPI are shown in the bottom row. Scale bar = 50 µm.
Figure 1 lipoplex binding and transfection efficiency in Madin–
darby canine kidney (MdcK) monolayers is significantly enhanced 
after prior loss of cell–cell contact. (a) Treatment of polarized MDCK 
cells with ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic 
acid (EGTA) results in loss of cell–cell contact, which is prevented by 
prior disruption of actin microfilaments by cytochalasin D, as evidenced 
by the localization of the tight junction-associated protein ZO-1. The 
insert shows a close-up of the punctuate ZO-1 staining in cytochalasin 
D/EGTA-treated cells. The loss of cell–cell contact before the addition 
of lipoplexes results in a massive increase in (b; scale bar is 30 µm, and 
also applies to panels in a) lipoplex binding to the cells and (c; scale 
bar is 100 µm) transfection efficiency. Lipoplex binding (d) (with SAINT-
2/DOPE) and transfection efficiency (e) (with Lipofectamine 2000) were 
quantified as indicated in Materials and Methods. Results with EGTA-
treated cells were set as 100%. An asterisk indicates statistical signifi-
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dependent on an intact actin cytoskeleton, is a prerequisite for the 
strong promotion of lipoplex binding.
AIIB2 blocking antibody inhibits lipoplex binding  
and transfection efficiency in eGtA-treated MdcK 
monolayers 
The binding pattern of lipoplexes to EGTA-­treated MDCK mono-­
layers indicates binding to receptors that are localized at the lateral 
plasma membrane. Two adhesion molecules that are enriched at the 
lateral membrane of MDCK cells, and to which function-­blocking 
antibodies against canine origin are available, are E-­cadherin and 
β1 integrin.17,18 To investigate their potential involvement in lipo-­
plex internalization, we investigated whether function-­blocking 
antibodies could abolish the enhancement in transfection efficiency 
of EGTA-­treated MDCK cells. Neither rr1 and rbαE-­cadherin (both 
blocking antibodies against E-­cadherin) nor RGD peptide (which 
primarily binds αv integrins) affected the transfection efficiency 
of MDCK cells after EGTA treatment (Figure 4a). Likewise, P2A4 
antibody against human (not canine) ICAM-­1 (an aspecific isotype 
control) did not affect the transfection efficiency. In contrast, AIIB2 
blocking antibody against β1 integrin almost completely abolished 
the transfection efficiency in EGTA-­treated monolayers (Figure 4a), 
and the extent of lipoplex binding was reduced by approximately 
50% under the same conditions (Figure 4b). These data suggest that 
multiple binding entities may exist on the cell surface but that those 
represented by the pool of β1 integrins play a prominent role in 
the internalization of lipoplexes leading to productive transfection. 
Interestingly, calcium is known to promote the bent (low-­affinity) 
conformation of integrins.19 In contrast to the bent conformation 
of integrins, in which their ligand-­binding site orients toward the 
plasma membrane, integrins in the high-­affinity conformation have 
been suggested to extend far above the surface of a cell, which will 
likely facilitate ligand binding. We therefore assume that (positively 
charged) lipoplexes bind extensively to the (negatively charged) 
regions that become exposed upon integrin activation. Subse-­
quently, lipoplexes piggyback along with the integrins that become 
internalized upon activation and/or ligand (lipoplex) binding.
In eGtA-treated MdcK monolayers lateral β1 integrin 
redistributes along the entire plasma membrane
To verify whether tight junction disruption by EGTA treat-­
ment results in the recruitment of laterally localized β1 integrin 
receptors, the surface topography of the receptor in control and 
EGTA-­treated MDCK monolayers was investigated by immu-­
nofluorescence. In control cells, permeabilized after fixation, β1 
integrin is mainly localized laterally (Figure 5a, cf. ref. 20). After 
EGTA treatment, the exclusive lateral distribution of β1 integrin 
is lost and the receptor redistributes at least partly to the entire 
plasma membrane (Figure 5a, EGTA). In MDCK cells pre-­treated 
with cytD, β1 integrin largely remains laterally distributed, but 
can also be found at the limiting membrane of large vesicular 
cytoplasmic structures (Figure 5a, cytD EGTA). Importantly, in 
non-­permeabilized MDCK cells, β1 integrin could be revealed 
only after EGTA treatment (data not shown). Taken together, the 
data indicate that apical membranes are devoid of the receptor; 
given that β1 integrin receptors at the lateral domain (i.e., between 
cells) are not accessible to (small) antibodies in non-­permeabi-­
lized polarized cells, it is similarly highly unlikely that (large) lipo-­
plexes (200–400 nm) are able to penetrate between neighboring 
cells to reach their receptors. Accordingly, in conjunction with the 
data showing an almost complete abolishment of transfection of 
the cells upon treatment with the β1 integrin blocking antibody 
(Figure 4a), these observations readily explain the relatively poor 
transfectability of polarized epithelial cells in monolayer culture.
transfection of MdcK monolayers after loss of 
cell–cell contact is cation dependent
To obtain further support for the role of integrins in lipoplex-­
mediated transfection, we examined the extent to which divalent 
cations affected transfection efficiency. It has been well established 
that integrin activity is modulated by divalent cations, including 
Ca2+, Mg2+, and Mn2+,21 which relies on divalent cation–induced 
changes in its conformational state.19,22 For example, Ca2+ and Mn2+ 
have been shown to act as inhibitor and activator, respectively, of 
β1 integrin activity.22,23 We therefore determined the transfection 
efficiency of EGTA-­treated MDCK cells, after a wash with Ca2+, 
Mg2+, or Mn2+. As shown in Figure 4c, whereas Mn2+ sustained 
the enhancement in transfection efficiency of EGTA-­treated cells, 
both Ca2+ and Mg2+ strongly inhibited transfection (Figure 4c). 
Figure 3 transmission electron microscopy of ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (eGtA)–treated Madin–
darby canine kidney (MdcK) monolayers incubated with lipoplexes. 
(a) EGTA-treated MDCK monolayers lose cell–cell contact and display a 
rounded morphology (scale bar = 2 µm). (b) Added Lipofectamine 2000 
lipoplexes (which are electron-dense) accumulate between the neigh-
boring cells, at the sites of prior cell–cell contact (scale bar = 560 nm). 
(c) An enlargement of the accumulation site of lipoplexes in b, reveal-
ing the presence of lipoplexes near/in coated pits (arrows) (scale bar = 
280 nm). (d) An enlargement of the lipoplexes in c (boxed area), reveal-
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Evidently, these effects are entirely consistent with the stimulatory 
and inhibitory effects on β1 integrin receptor activity of Mn2+, on 
the one hand, and Ca2+, on the other, supporting the involvement 
of integrins in lipoplex-­mediated transfection of MDCK cells after 
EGTA treatment.
down-regulation of cell surface β1 integrin  
expression inhibits transfection of MdcK cells
As an alternative approach to determining the role of β1 integ-­
rin in lipoplex-­mediated transfection we used RNA interference. 
MDCK cells were treated with small interfering RNA (siRNA) 
directed against canine β1 integrin (sicanb1), and, as controls, 
murine β1 integrin (simurb1) and influenza hemagglutinin. Cells 
treated with sicanb1 formed seemingly perfect confluent mono-­
layers (Figure 5b), but, as anticipated, cell–cell interactions were 
weakened, as reflected by a diminished value of the transepithe-­
lial resistance compared with control cells (Figure 5b). Indeed, 
within the monolayers, cell areas with a significant reduction in 
β1 integrin expression were clearly visible by immunofluores-­
cence microscopy (Figure 5d). Consistent with this observation, 
quantitation by means of immunoprecipitation of biotinylated β1 
integrin revealed that the total cell surface expression of β1 inte-­
grin in siRNA-­treated cells was inhibited by 70% compared with 
control cells (Figure 5e). Importantly, the transfection efficiency 
of β1 integrin–depleted monolayers after sicanb1 treatment was 
reduced by 80% compared with cells treated with the control 
siRNA simurb1 (Figure 5c). Cells treated with siRNA against 
hemagglutinin showed some inhibition in transfection, but the 
inhibition seen in this case was statistically insignificant. As can 
be seen from the nuclear staining in Figure 5d, all siRNA-­treated 
monolayers show some delay in growth compared with control 
cells. However, no specific effects of sicanb1 treatment on cell 
growth or viability were observed under these conditions.
exposure of adhesion receptors promotes  
transfectability of a variety of cell types
As neural stem cells can be grown ex vivo in clusters, in which 
the cells display extensive cell–cell adhesion,24 a similar protocol 
for improving surface exposure of receptors was applied as for 
MDCK cells. Interestingly, as shown in Figure 6a, after EGTA 
treatment, the transfection efficiency of neural stem cells was 
substantially increased. The number of transfected cells and the 
Figure 4 AIIB2 β1 integrin blocking antibody inhibits lipoplex binding and transfection efficiency in ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (eGtA)–treated Madin–darby canine kidney (MdcK) monolayers. (a) Incubation of EGTA-treated MDCK monolayers 
with the β1 integrin blocking antibody AIIB2 inhibits transfection, whereas incubation with RGD/RAD peptides, the E-cadherin blocking antibodies 
rr1 and RbαEcad, and P2A4 ICAM-1 blocking antibody (which does not recognize canine ICAM-1 and thus serves as a negative control for steric hin-
drance of antibodies as such) are without effect. (b) Binding of (SAINT-2/DOPE) lipoplexes is significantly reduced (t-test; P < 0.05) in cells incubated 
with AIIB2 antibodies when compared with cells incubated with rr1 antibodies (EGTA condition set as 100%). (c) Whereas Mn2+ sustains transfec-
tion with Lipofectamine 2000 lipoplexes in EGTA-treated cells, Ca2+ and Mg2+ inhibit transfection. Transfection efficiency after EGTA treatment set as 
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extent of reporter gene expression per cell were enhanced, which 
is consistent with an increase in receptor accessibility and lipoplex 
internalization upon loss of cell–cell contacts.
Transfection of EL4 T lymphoma and S180 sarcoma cells was 
not significantly altered upon EGTA treatment (data not shown). 
This result was not unexpected, as these cells typically grow in sus-­
pension as single cells, implying that these cells are essentially not 
engaged in cell–extracellular matrix (ECM) or cell–cell adhesion 
interactions (Figure 6b and c). To stimulate artificially cell surface 
recruitment of cell adhesion molecules, EL4 cells were grown in 
the presence of the ECM protein laminin and briefly stimulated 
with phorbol 12-­myristate 13-­acetate (PMA) before transfection. 
In the presence of laminin, EL4 cells readily formed large homo-­
typic cell aggregates that remained in suspension (Figure 6b). 
Additional treatment with PMA stimulated EL4 cell activation, 
as evidenced by the secretion of the pro-­inflammatory cytokine 
interferon-­γ. Indeed, incubation of EL4 cells with laminin and 
PMA resulted in high levels of interferon-­γ secretion (68.5 pg/ml) 
as measured 24 hours after stimulation, whereas incubation with 
either laminin or PMA alone resulted in low interferon-­γ secretion 
(<10 pg/ml). Similar results were obtained when collagen was used 
instead of laminin (data not shown). Importantly, upon addition 
of PMA, EL4 aggregates became less tight, allowing for the pen-­
etration of lipoplexes between cells. We compared the transfec-­
tion efficiencies of PMA-­stimulated EL4 cells in the presence and 
absence of laminin. As shown in Figure 6b, activated (LN/PMA) 
EL4 cells displayed a fourfold increase in transfection efficiency 
relative to non-­activated (PMA) cells. Moreover, the increase 
in transfection efficiency could be inhibited by RGD peptides 
(Figure 6b, graph), indicating the involvement of integrins.25,26
Finally, because incubation in the presence of cis-­ 
polyunsaturated fatty acids has been said to activate integrins and 
enhance cell adhesion of tumor cells,27 we incubated S180 cells 
with linoleic acid before transfection. In the presence of linoleic 
acid, S180 cells formed large cell clusters, indicating the induc-­
tion of cell–cell adhesion by linoleic acid (Figure 6c). These clusters 
Figure 5 Interference rnA (rnAi)–mediated down-regulation of β1 integrin expression inhibits transfection efficiency in Madin–darby 
canine kidney (MdcK) monolayers. (a) In polarized MDCK cells, β1 integrin is predominantly localized at the lateral surface (control). Upon treat-
ment with ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), β1 integrin redistributes along the entire cell surface (EGTA). 
This is prevented by prior treatment with cytochalasin D (cytD), which causes the partial internalization of β1 integrin into large vacuolar struc-
tures (cytD EGTA). Size bar indicates 10 µm. (b) Down-regulation of β1 integrin expression by RNAi (sicanb1) reduces the transepithelial resistance 
(TER) of the MDCK monolayer when compared with cells treated with the control siRNAs simurb1 and influenza hemagglutinin (siHA). (c) Down- 
regulation of β1 integrin expression by RNAi (sicanb1) reduces transfection efficiency with Lipofectamine 2000 lipoplexes when compared with cells 
treated with the control siRNAs simurb1 and siHA (t-test, P < 0.05). Treatment of MDCK cells with sicanb1, but not simurb1 or siHA, reduces surface 
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were significantly (threefold) better transfected than single cells 
(Figure 6c, graph).
dIscussIon
The data presented demonstrate that lipoplex-­mediated transfec-­
tion of MDCK monolayers can be mediated by a specific class 
of adhesion molecules, i.e., β1 integrin receptors, made acces-­
sible upon EGTA treatment. The “specificity” of the receptor is 
highly intriguing, as transfection is virtually abolished when it 
is blocked by a specific antibody, AIIB2, and lipoplex binding is 
reduced by approximately 50% under the same conditions. These 
data suggest that multiple binding entities may exist on the cell 
surface but that those represented by the pool of β1 integrins 
play a prominent role in the internalization of lipoplexes lead-­
ing to productive transfection. In future work it will be of inter-­
est to improve the transfection efficiency by means of targeting 
of lipoplexes to β1 integrin receptors. Future studies are also 
required to investigate the mechanism involved in the endocy-­
totic internalization of β1 integrin receptors. In sub-­confluent 
MDCK cells, transfection was strongly inhibited by prior treat-­
ment of the cells with methyl-­β-­cyclodextrin and chlorpromazine, 
indicating the involvement of clathrin-­mediated endocytosis.9 
However, in confluent cells, these inhibitors could not be used 
as the loss of cell–cell contact induced by EGTA results from the 
endocytosis of cell junctional receptors such as E-­cadherin.28 Prior 
treatment with methyl-­β-­cyclodextrin or chlorpromazine would 
interfere with the endocytosis of E-­cadherin, preventing the loss of 
cell–cell contact. Likewise, incubation of MDCK cells with EGTA 
at 10 °C (a non-­permissive temperature for endocytosis) did not 
result in loss of cell–cell contact (I.S.Z., unpublished results), indi-­
cating that energy-­dependent processes, such as endocytosis, are 
responsible for the rounding-­up of cells upon EGTA treatment.
To investigate the generality of the observation that adhesion 
receptors serve as “natural” cell surface receptors for lipoplexes, 
we set out to challenge adhesion receptors in difficult-­to-­transfect 
primary cells and suspension cells. As (primary) neurospheres 
display extensive cell–cell contact, these cells could be similarly 
treated with EGTA to make adhesion receptors accessible to 
lipoplexes. Indeed, in EGTA-­treated neurospheres transfection 
efficiency was significantly enhanced (Figure 6a). EL4 and S180 
suspension cells, which do not display cell–cell adhesion, could be 
artificially stimulated to recruit and/or activate cell adhesion mol-­
ecules to their cell surface when grown in the presence of specific 
ECM proteins and lipids, respectively. After cell surface recruit-­
ment of adhesion receptors in these cells, transfection efficiency 
was significantly enhanced (graphs in Figure 6b and c). Although 
beyond the scope of this article, it would be of interest to show 
which adhesion receptors mediate lipoplex internalization in the 
different cell types. In EL4 cells the αLβ2 integrin receptor would 
be a likely candidate.
Notably, in MDCK cells transfection was not inhibited by 
RGD peptide, whereas in EL4 cells RGD peptide did inhibit trans-­
fection. This indicates that the different treatments in the differ-­
ent cell types lead to expression/exposure of different (sets of) 
adhesion receptors. It seems contradictory for laminin to induce 
RGD-­dependent adhesion in EL4 cells, as laminin generally binds 
to different subsets of integrins (α3, α6) than the ones inhibited 
by RGD (α5, αv). However, it should be noted that in our experi-­
mental set-­up, the presence of laminin induces cell–cell contact 
and not cell–ECM (LN) contact; i.e., laminin is a non-­adhesive 
substrate. Also, it has been reported in the literature that laminin 
contains an RGD motif.29,30
Although the expression pattern of adhesion receptors will likely 
vary among various cell types and at the moment we do not exclude 
the potential involvement of other classes of adhesion receptors 
besides integrins (i.e., immunoglobulins, selectins, and cadherins), 
our study clearly demonstrates that the accessibility/recruitment of 
adhesion receptors on the cell surface can be employed to achieve 
efficient transfection of cells that are known to be highly resistant to 
transfection, such as polarized epithelial cells.
Furthermore, the data suggest an apparent and interesting 
parallel between cellular “receptors” for entry of viruses and for 
entry of particles such as lipoplexes, possibly driven by charge 
and size. It is apparent that the current approach will be particu-­
larly relevant to ex vivo gene therapy as it offers a relatively simple 
means greatly to improve transfection efficiency of cells, including 
stem cells, whose therapeutic impact may have been limited thus 
far owing to poor transfection susceptibility.
Figure 6 Activation of cell adhesion receptors enhances transfec-
tion efficiency of neural stem cells, el4 t lymphocytes, and s180 
sarcoma cells. (a) Incubation of ethylene glycol-bis(2-aminoethyl-
ether)-N,N,N′,N′-tetraacetic acid (EGTA)–treated neurospheres with 
Lipofectamine 2000 lipoplexes results in a significant increase in green 
fluorescent protein (GFP)–positive cells when compared with untreated 
neurospheres. (b) Incubation of EL4 T lymphocytes in the presence of 
laminin results in the formation of large cell clusters that are significantly 
better transfected with Lipofectamine 2000 lipoplexes after phorbol 12-
myristate 13-acetate (PMA) stimulation when compared with cells incu-
bated in the absence of laminin (graph; an asterisk indicates statistical 
significance compared with PMA-treated cells). The increased transfec-
tion efficiency in EL4 cells treated with laminin/PMA is prevented by 
pre-incubation with RGD peptides (graph; a double asterisk indicates 
statistical significance compared with LN/PMA-treated cells). (c) S180 
sarcoma cells form clusters in the presence of linoleic acid that show 
a threefold increase in transfection efficiency with Lipofectamine 2000 
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MAterIAls And Methods
Cell culture. MDCK cells were grown in Dulbecco’s modified Eagle’s 
medium (Gibco, Breda, The Netherlands) containing 10% fetal bovine 
serum, 2 mM l-­glutamine (Gibco), 100 U/ml penicillin (Invitrogen), 
and 100 mg/ml streptomycin (Invitrogen) at 37 °C and 5% CO2. Cells 
were plated at 2 × 105 cells/cm2 in Transwell plates from Costar (Corning 
Life Sciences, Acton, MA). The next day, the cell culture medium was 
refreshed. At day 3 after plating, cell resistance was measured with a 
Millicell-­ERS device (Millipore, Billerica, MA) and experiments were 
performed.
Neural stem cells, isolated from murine brain, were grown as neu-­
rospheres in neurobasal medium (Gibco) supplemented with 2% B27 
(Gibco), 1% glutamax-­1 (Invitrogen), 2 mM l-­glutamine (Gibco), 100 U/
ml penicillin (Invitrogen), 100 mg/ml streptomycin (Invitrogen), 20 ng/ml 
basic fibroblast growth factor (bFGF) (Invitrogen), and 20 ng/ml epider-­
mal growth factor (Invitrogen).
EL4 cells (murine T-­lymphocytes) were grown in Iscoves modi-­
fied Dulbecco’s medium with glutamax-­1 (Gibco) and 10% fetal bovine 
serum.
S180 sarcoma cells were grown in Dulbecco’s modified Eagle’s Medium 
containing 10% fetal bovine serum, 2 mM l-­glutamine (Gibco), 100 U/ml 
penicillin (Invitrogen), 100 mg/ml streptomycin (Invitrogen), and 1 mM 
sodium pyruvate (Gibco).
Lipoplex binding and internalization. Three-­day-­old MDCK cultures 
were treated with the calcium chelator EGTA (2 mM, Sigma, St. Louis, 
MO) until cell–cell contact was lost (typically 15–45 minutes at 37 °C). 
Then cultures were washed with ice-­cold serum-­free medium (Dulbecco’s 
modified Eagle’s medium) and cooled. Subsequently, rr1 (anti-­E cadherin) 
and AIIB2 (anti-­β1 integrin) blocking antibody (Developmental Studies 
Hybridoma Bank, University of Iowa, IA; 10 µg/ml; 0.1% bovine serum 
albumin) were added for 30 minutes on ice. Lipoplexes with a positive:
negative charge ratio of 2.5:1 (average size 200 nm), composed of N-­ 
rhodamine-­PE-­labeled (0.5 mol%) SAINT-­2/DOPE (synthesized accord-­
ing to Meekel et al.31) and pEGFP-­N1 (Clontech, Mountain View, CA), 
were added and left with the cells for 1 hour on ice (binding). Cells were 
extensively washed (three times) with ice-­cold Hank’s buffered salt solu-­
tion (Gibco), filters were excised, and lipoplex binding was measured with 
fluorescence microscopy (Olympus, Tokyo, Japan) and quantified using 
Scionimage (Scion Corporation, Frederick, MA) software. SDs were cal-­
culated from at least three separate experiments performed in duplicate. 
Statistical significance was determined using the Student’s t-­test. Experi-­
ments in which we used Lipofectamine 2000 with FITC-­ODNs gave simi-­
lar results. In addition, the effect of EGTA on lipoplex internalization and 
transfection efficiency of MDCK cells is comparable to SAINT-­2/DOPE 
and Lipofectamine 2000. For internalization, lipoplexes composed of Lipo-­
fectamine 2000 and FITC-­ODNs (Biognostik, Göttingen, Germany) were 
added to cells for 1 hour at 37 °C (internalization). Cells were extensively 
washed with ice-­cold Hank’s buffered salt solution (Gibco), filters were 
excised, and nuclear accumulation of FITC-­ODNs was visualized with 
fluorescence microscopy (Olympus).
Transfection of MDCK cells and neurospheres. Three-­day-­old MDCK cul-­
tures were incubated with lipoplexes (made in serum-­free medium) com-­
posed of Lipofectamine 2000 (Invitrogen) and pEGFP-­N1 (Clontech) at 
37 °C, according to the manufacturer’s protocol and typically adding 0.5 µg 
of plasmid DNA per well. The transfection efficiency was determined the 
next day. Cells were fixed with 4% paraformaldehyde (Sigma) and nuclei 
were stained with 4′,6-­diamidino-­2-­phenylindole (Sigma). For each condi-­
tion, 5,000 cells were counted. Transfection efficiency is expressed as the 
number of green fluorescent protein–positive cells per 5,000 cells. Before 
lipoplex incubation, cells were treated with 2 mM EGTA until the loss of 
cell–cell contact. cytD (Sigma) was used to disrupt actin microfilaments 
at 1 µg/ml. After EGTA treatment, cells were incubated with blocking 
 antibodies (10 µg/ml; 0.1% bovine serum albumin) and GRGDSP (RGD) 
and GRADSP (RAD) peptides (200 µg/ml; Calbiochem, Nottingham, UK) 
for 1 hour (on ice) or washed with freshly prepared 2 mM Ca2+, Mg2+, or 
Mn2+. SDs were calculated from at least three separate experiments per-­
formed in duplicate. Statistical significance was determined using the 
Student’s t-­test. Similar to MDCK cells, neurospheres were incubated with 
2 mM EGTA before the addition of lipoplexes. Transfection efficiency was 
measured the next day.
Transfection of EL4 cells. EL4 cells were plated on ECM-­coated 12-­well 
plates 1 day before transfection. Plates were coated with laminin (10 µg/ml; 
Sigma), collagen (5 µg/ml; Boehringer-­Mannheim, Germany), fibronectin 
(10 µg/ml; Sigma), and poly-­ornithine (0.01%; Sigma). After stimulation 
with PMA (50 ng/ml; 30 minutes; Sigma), cells were incubated with lipo-­
plexes for 4 hours (0.5 µg plasmid DNA/well). Optionally, EL4 cells were 
incubated with RGD and RAD peptide (200 µg/ml) before the addition of 
lipoplexes. The next day transfection efficiency was determined by FACS 
analysis (Elite, Coulter, Hialeah, FL; λex. 488 nm, λem. 530 nm, 5,000 events). 
SDs were calculated from at least three separate experiments performed in 
duplicate. Statistical significance was determined using the Student’s t-­test
Transfection of S180 sarcoma cells. S180 cells were plated at 2 × 105 cells/
ml and incubated with 200 nmol/ml linoleic acid methyl ester (Merck, 
Darmstadt, Germany) for 24 hours before transfection. Lipoplexes com-­
posed of Lipofectamine 2000 and containing 1 µg plasmid DNA were 
added. Transfection efficiency was determined the next day by fluorescence 
microscopy. SDs were calculated from at least three separate experiments 
performed in duplicate. Statistical significance was determined using the 
Student’s t-­test
Antibodies. Blocking antibodies against β1 integrin (AIIB2), E-­cadherin 
(rr1), and ICAM-­1 (P2A4) were obtained from the Developmental Stud-­
ies Hybridoma Bank. RbαEcadherin was a gift from Dr. M. Wheelock. 
The antibody directed against ZO-­1 was from Zymed (San Francisco, 
CA). Alexa fluor 488 and 568 secondary antibodies were purchased from 
Molecular Probes (Eugene, OR).
siRNA treatment of MDCK cells. siRNA duplexes against canine (XM_
535143) and murine β1 integrin (NM_010578) were synthesized by Euro-­
gentec (Seraing, Belgium). Sequences of siRNA duplexes were 5′ GCUC 
CAGCCAGAAGAUAUUdTdT 3′ and 5′ GCAUUGGCUUUGGCUCAU 
UdTdT 3′ for canine and murine β1 integrin, respectively. siRNA against 
hemagglutinin (5′ UAUGCGACAGUCCUCCUCACCAdTdT 3′) was 
a gift from Dr. A. Huckriede (University of Groningen, The Nether-­
lands). MDCK cells were treated with siRNA (80 nM) on day 1 and day 
2 after plating, using Lipofectamine 2000 according to the manufacturer’s 
instructions. (Note that trypsinization of sicanb1-­treated MDCK cells ren-­
dered the cells with a diminished capacity to restore attachment to a cell 
culture dish/filter. Therefore, cells were treated twice with siRNA without 
replating.) On day 3 the transepithelial resistance was measured (Millicell-­
ERS, Millipore) and experiments were performed. Down-­regulation of β1 
integrin level was determined by immunostaining and immunoprecipita-­
tion, using the AIIB2 antibody.
Immunoprecipitation of β1 integrin. siRNA-­treated MDCK mono-­
layers were treated with EGTA, cooled on ice, and biotinylated 
(EZ-­link Sulfo-­NHS-­LC-­Biotin; Pierce Biotechnology, Rockford, IL) for 
30 minutes on ice. Subsequently, cells were lysed (cold) in 1% Triton X-­100, 
supplemented with protease inhibitors (Complete Mini protease inhibitor 
cocktail; Roche, Indianapolis, IN). β1 integrin was immunoprecipitated, 
using AIIB2 antibody coupled to protein G-­sepharose beads, following 
standard procedures. Beads containing antibody–antigen complexes were 
re-­suspended in sample buffer (reducing) and boiled for 5 minutes. Beads 
were spun down, and supernatants were applied onto sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (10%), followed by transfer 
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onto nitrocellulose membranes. Membranes were blocked with 5% milk 
in Tris-­buffered saline Tween-­20 and incubated with streptavidin-­horse-­
radish peroxidase. Blots were processed for enhanced chemiluminescence 
(ECL; Amersham, Buckinghamshire, UK) detection. Bands were quanti-­
fied using Scionimage software.
Transmission electron microscopy of EGTA-treated MDCK cells. After 
EGTA treatment, MDCK cells were cooled on ice and incubated with lipo-­
plexes for 1 hour. Subsequently, cells were warmed to 37 °C and incubated 
for 10 minutes to initiate internalization of lipoplexes. Cells were fixed for 
1 hour on ice in 1.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, 
containing 1% sucrose. After postfixation in 1% OsO4/1.5% K4Fe(CN)6, 
cells were dehydrated in graded alcohol series and embedded in Epon 812. 
After polymerization for 4 days at 45 °C, ultra-­thin sections were cut and 
stained with 1% tannic acid and 1% uranylacetate. (All chemicals used for 
the processing of cells for investigation by transmission electron micros-­
copy were from Sigma.) The sections were examined using a Philips CM 
100 electron microscope (Eindhoven, The Netherlands) operating at 60 kV 
and micrographs were taken.
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